NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/18/2018
Back to search
Official data from USPTO
NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION, INC.
ST13
US500000075390393Class
36
Filing
75390393
Registration
2193883
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
10/18/2018
Trademark type
Word
Nice classes
36
Filing date
11/14/1997
Registration date
10/06/1998
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2018
Last transaction
10/18/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1991-10-00
First use in commerce
1991-10-00
Drawing code
1
Owner type
03
Owner location
Flemington, NJ, US
Examiner
WILLIAMS, IRENE
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
National Immunotherapy Cancer Research Foundation, Inc.
Representatives
Vincent V. Carissimi PEPPER HAMILTON LLP
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
PHILANTHROPIC FOUNDATION SERVICESFUNDING EDUCATION AND RESEARCH IN THE FIELD OF CANCER IMMUNOTHERAPY
Publications
History of USPTO decisions and trademark events.
21 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/18/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/18/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/16/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
10/08/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/15/2010
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/15/2010
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/22/2008
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/22/2008
PLGL
ASSIGNED TO PARALEGAL
03/22/2008
E89R
TEAS SECTION 8 & 9 RECEIVED
03/13/2008
CFIT
CASE FILE IN TICRS
08/03/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/02/2004
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/07/2004
PAPER RECEIVED
10/07/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/1998
PUBO
PUBLISHED FOR OPPOSITION
07/14/1998
NPUB
NOTICE OF PUBLICATION
06/12/1998
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/1998
CNEA
EXAMINER'S AMENDMENT MAILED
04/23/1998
DOCK
ASSIGNED TO EXAMINER
04/13/1998
Continuous trademark protection
Get notified about every new filing that threatens NATIONAL IMMUNOTHERAPY CANCER RESEARCH FOUNDATION, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.